Bone News and Research

RSS

Research: Human neural stem cells could improve blood flow in critical limb ischemia

New research has shown human neural stem cells could improve blood flow in critical limb ischemia through the growth of new vessels. Critical limb ischemia is a disease that severely obstructs arteries and reduces the blood flow to legs and feet. CLI remains an unmet clinical problem and with an ageing population and the rise in type II diabetes, the incidence of CLI is expected to increase.

27 Nov 2013

Viewpoints: Senate should reconsider treaty on protections for people with disabilities; HHS treading wrong way on payments for bone marrow donors

About a year ago the Senate fell five votes short of ratifying an international treaty that would improve protections for the disabled. It was an ignoble spectacle as the opponents rebuffed Bob Dole, a former colleague and disabled veteran, who came to the Senate floor to lobby for it.

26 Nov 2013

DKMS selects Remedy Informatics to provide analytics and pattern recognition technology

Remedy Informatics, Inc., the leading provider of registry-based informatics software for life sciences research and healthcare delivery, announced that DKMS, the world's largest bone marrow donor center, has selected Remedy's informatics solutions to solidify its position as an innovator and leader of hematopoietic stem cell transplantation worldwide.

26 Nov 2013

Dysregulation of epigenetic marks may play role in chronic kidney disease, shows study

The research of physician-scientist Katalin Susztak, MD, PhD, associate professor of Medicine in the Renal Electrolyte and Hypertension Division, at the Perelman School of Medicine, University of Pennsylvania, strives to understand the molecular roots and genetic predisposition of chronic kidney disease.

26 Nov 2013

Anti-epileptic drugs, bone loss and supplements

Antiepileptic drugs are medications used to prevent and control seizure disorders. These medications are also frequently used for other diagnoses other than seizures, however this current study concentrated on patients with a seizure disorder.

25 Nov 2013

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency's: Committee for Medicinal Products for Human Use has adopted a positive opinion for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.

25 Nov 2013

Research: Notch protein plays essential role in triggering T-cell development

The lab of Avinash Bhandoola, PhD, professor of Pathology and Laboratory Medicine, has studied the origins of T cells for many years. One protein called Notch, which has well-known roles in the development of multiple tissues, plays an essential role in triggering T-cell development.

25 Nov 2013

Scientists find link between airborne allergies and risk of blood cancers in women

A team of scientists looking into the interplay of the immune system and cancer have found a link between a history of airborne allergies - in particular to plants, grass and trees - with risk of blood cancers in women.

25 Nov 2013

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

Bayer HealthCare and Onyx Pharmaceuticals, Inc., an Amgen subsidiary, today announced that the U.S. Food and Drug Administration has approved a supplemental New Drug Application for the oral multi-kinase inhibitor NEXAVAR (sorafenib) tablets for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment.

23 Nov 2013

BonAlive Biomaterials launches osteostimulative BonAlive putty

BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices, today announced the launch of a patented, ready-to-use and mouldable version of their osteostimulative BonAlive bioactive glass bone regeneration technology.

22 Nov 2013

NYSCF partners with NIH to generate stem cell for treating rare diseases

In what is anticipated to be a major step forward for rare disease research, The New York Stem Cell Foundation (NYSCF) Research Institute is partnering with the National Institutes of Health (NIH) Undiagnosed Disease Program (UDP).

22 Nov 2013

Hologic to highlight groundbreaking imaging products at RSNA 2013

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced the groundbreaking imaging products it will highlight at the 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America at McCormick Place, Chicago from December 1st through 5th.

From Hologic, Inc. 21 Nov 2013

AAOS releases Appropriate Use Criteria covering five different treatments for rotator cuff injuries

Each year, close to 2 million people in the United States visit their doctor for shoulder pain associated with a rotator cuff injury. Approximately one-third of rotator cuff tears will require surgery, with the remaining injuries benefiting from nonsurgical treatment including pain medication and rehabilitation exercises. To help physicians determine the best treatment for each patient, the American Academy of Orthopaedic Surgeons recently released Appropriate Use Criteria covering five different treatments for rotator cuff injuries.

21 Nov 2013

DNA-damaging drug and MK2 inhibitor combination could be effective against cancer

About half of all cancer patients have a mutation in a gene called p53, which allows tumors to survive and continue growing even after chemotherapy severely damages their DNA.

20 Nov 2013

BioCardia reports positive results for Transendocardial Autologous Cells in Ischemic Heart Failure Trial

BioCardia, Inc., a leader in cardiovascular regenerative medicine, today announced positive 12-month results for the randomized Transendocardial Autologous Cells (MSC or BMC) in Ischemic Heart Failure Trial (TAC-HFT).

20 Nov 2013

University of Sydney researchers identify new type of medication for osteoporosis

University of Sydney researchers have discovered a new and promising treatment for osteoporosis which is easily delivered in water soluble form.

20 Nov 2013

Data from CT scans can be used with 3-D printers to make accurate copies of fossilized bones

Data from computed tomography (CT) scans can be used with three-dimensional (3-D) printers to make accurate copies of fossilized bones, according to new research published online in the journal Radiology.

20 Nov 2013

Heart failure patients receiving LVAD may benefit from injection of powerful cells directly into heart

A multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network, led by Icahn School of Medicine at Mount Sinai, have found end-stage heart failure patients who receive a surgically implanted left ventricular assist device heart pump may also benefit from a single dose of millions of powerful cells injected directly into their heart during surgery.

19 Nov 2013

Researchers study safety of transendocardial stem cell injection in patients with ischemic cardiomyopathy

Alan W. Heldman, M.D., of the University of Miami Miller School of Medicine, and colleagues conducted a study to examine the safety of transendocardial stem cell injection with autologous mesenchymal stem cells and bone marrow mononuclear cells in patients with ischemic cardiomyopathy.

19 Nov 2013

Study: Blood cell growth factor improves effects of exercise in patients with peripheral artery disease

A blood cell growth factor can boost the effects of exercise in improving mobility for patients with peripheral artery disease, a clinical study has shown.

19 Nov 2013

Bone News and Research

Research: Human neural stem cells could improve blood flow in critical limb ischemia

Viewpoints: Senate should reconsider treaty on protections for people with disabilities; HHS treading wrong way on payments for bone marrow donors

DKMS selects Remedy Informatics to provide analytics and pattern recognition technology

Dysregulation of epigenetic marks may play role in chronic kidney disease, shows study

Anti-epileptic drugs, bone loss and supplements

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Research: Notch protein plays essential role in triggering T-cell development

Scientists find link between airborne allergies and risk of blood cancers in women

NEXAVAR tablets receive FDA approval for treatment of patients with thyroid cancer

BonAlive Biomaterials launches osteostimulative BonAlive putty

NYSCF partners with NIH to generate stem cell for treating rare diseases

Hologic to highlight groundbreaking imaging products at RSNA 2013

AAOS releases Appropriate Use Criteria covering five different treatments for rotator cuff injuries

DNA-damaging drug and MK2 inhibitor combination could be effective against cancer

BioCardia reports positive results for Transendocardial Autologous Cells in Ischemic Heart Failure Trial

University of Sydney researchers identify new type of medication for osteoporosis

Data from CT scans can be used with 3-D printers to make accurate copies of fossilized bones

Heart failure patients receiving LVAD may benefit from injection of powerful cells directly into heart

Researchers study safety of transendocardial stem cell injection in patients with ischemic cardiomyopathy

Study: Blood cell growth factor improves effects of exercise in patients with peripheral artery disease

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News